Recognizing promising house officers pursuing a career in academic ophthalmology and vision research.

The AUPO/RPB Resident and Fellow Research Forum was established through a grant provided by Research to Prevent Blindness (RPB). The AUPO believes strongly that skills learned by participating in research are an invaluable component of the education of an ophthalmologist. The establishment of the Resident and Fellow Research Forum acknowledges the importance of research in ophthalmic education and is intended to encourage the most promising house officers to pursue a career in academic ophthalmology and vision research. Through this forum AUPO promotes excellence in research by residents and fellows and identifies and supports individuals considering a career in ophthalmic research. Each year, AUPO schedules a session for the Forum as an integral part of the annual meeting. Travel-related expenses for the meeting are covered by AUPO; winners receive a cash award of $500 and a commemorative certificate.

Nominations open in July and close in September.

Chuter

Benton Chuter, MD, MS
Hamilton Eye Institute - University of Tennessee Health Science
Center

Benton Chuter is a pre-residency glaucoma research fellow at the Hamilton Eye Institute (HEI) of the University of Tennessee Health Science Center. He grew up in the San Francisco Bay Area and pursued his undergraduate and master’s degrees at Stanford University, studying biology and mechanical engineering while also racing in the top eight for Stanford’s varsity rowing team. After working as a consultant in medical device design, he completed his medical degree at the University of California San Diego. Now at HEI, he brings over a decade of research experience and expertise in engineering, medicine, and AI. Leading a team in Dr. Monica Jablonski’s lab, he develops and applies novel deep learning-based tools to assess measures of optic nerve health. Benton is one of the first to use deep learning to quantify the effect of a pharmaceutical agent on optic nerve morphology. Also a proud father, he considers his son to be his greatest invention yet. As an aspiring ophthalmologist, Benton hopes to continue integrating his academic, engineering, and clinical interests to improve and broaden access to ophthalmologic care.

 

Dhodapkar

Rahul Dhodapkar, MD
University of Southern California School of Medicine

I am a dedicated resident physician in ophthalmology at the University of Southern California with expertise in complex computational modeling of molecular genetics and diagnostic imaging data. As a former core software engineer at MongoDB (a leading database technology), I also have expertise in the management and manipulation of large datasets. My previous work includes developing new approaches for the analysis of single-cell data based on large language models with a focus on cross-species applications (e.g. determining the applicability of insights derived in non-human model systems to human vision) as well as perturbation prediction (e.g. predicting the effect of a new drug or genetic manipulation in a never-before-seen context in silico). I have also authored work applying state-of-the-art computer vision techniques to perform automated quality control of OCTA images. Aligned with my goal of becoming a physician-scientist in our field, I remain focused on developing new techniques for the application of artificial intelligence to improve both the clinical practice of ophthalmology and the basic science that drives our understanding of ophthalmic pathology. I am excited to present our work on automated measurement of strabismus using computer vision techniques at the research forum this year.

 

Hauser

Blake Hauser, MD, PhD
Mass Eye and Ear - Harvard Medical School Department of Ophthalmology

Blake Hauser, MD, PhD, is currently a PGY-2 resident in ophthalmology at Mass Eye and Ear. She graduated from the Health Sciences and Technology track at Harvard Medical School while also earning a PhD in Biophysics through the Harvard/MIT MD-PhD program. Her doctoral work focused on protein engineering and structural virology, and this was funded by an NIH F30 grant award. She has a longstanding research interest in understanding the molecular basis of human disease, which she first pursued as a Morehead-Cain Scholar at the University of North Carolina at Chapel Hill and later as a Churchill Scholar at the University of Cambridge. Blake has published over 70 peer-reviewed papers and earned multiple awards including the Dr. John D. and Gretchen H. Bullock Ophthalmology Award and the Soma Weiss Award for Excellence in Research from Harvard Medical School. Currently, she works with Elizabeth Rossin, MD, PhD, on leveraging analysis of protein structures to obtain increased insight into the genetic basis of inherited retinal diseases, in parallel with her clinical training in ophthalmology. She aspires to a career as an academic surgeon-scientist, helping to preserve patients’ vision while simultaneously advancing scientific understanding of vision-threatening processes.

 

Xu

Vincent (Runzhe) Xu

Vincent (Runzhe) Xu is a second-year MD/PhD student at UT Southwestern. He grew up in Nanjing, China, and attended UCLA for college, where he graduated summa cum laude with BSc in Biochemistry and Neuroscience. During and after his undergraduate studies, he conducted neuroscience research under the mentorship of HHMI Investigator Dr. Larry Zipursky. His work elucidated novel roles of vision in regulating mammalian visual cortex development by leveraging high-throughput single-cell sequencing and spatial transcriptomics. His research has led to multiple publications in high-impact journals, including Cell, Nature, and Cancer Cell, as well as a first-author publication in PNAS. With a growing interest in vision science and the emerging field of cancer neuroscience, he subsequently joined the UT Southwestern MSTP program and began research under the mentorship of Dr. William J. Harbour to investigate the biological underpinnings of intraocular tumorigenesis. His recent work focuses on dissecting the molecular heterogeneity of human retinoblastoma and identifying conserved transcriptional programs associated with tumor malignancy and treatment response by integrating high-throughput omics and bioinformatics. Vincent plans to pursue residency training in ophthalmology and aspires to become a physician-scientist who bridges clinical care and laboratory research to develop new treatments for sight-threatening diseases.

Forum YearPresenter NameAcademic InstitutionPresentation Title
2025Kristin Ates Hicks, MD, PhDUniversity of FloridaUsing a Modified Arrestin1 to Increase Glycolysis as a Gene-Agnostic Tool to Slow Retinal Degeneration
2025Whitney Sambhariya, MD, PhDJohns Hopkins/Wilmer Eye InstituteThe Role of PTEN in Intraocular Stem Cell Transplantation Neuroprotection and Survival
2025Drew Voigt, MD, PhDNorthwestern University/Feinberg School of MedicineOcular Pro-Angiogenic Macrophages are Shared Across Species and Neovascular Diseases
2025Seyedeh (Maryam) Zekavat, MD, PhDHarvard/Massachusetts Eye and EarMulti-omics Analyses Link Genetics, Metabolomics, Photoreceptor Thickness, and Age-related Macular Degeneration in the UK Biobank -
2024David Camacho, BSUniversity of PennsylvaniaGene Therapy Validation Using Induced Pluripotent Stem Cell-Derived Retinal Ganglion Cells
2024Christie Campla, PhDCase Western Reserve UniversityHepatic HIF Stabilization by Novel Carbonyl Glycine Derivatives Protects Against Oxygen-Induced Retinopathy
2024Rami Gabriel, MDDuke University Eye CenterDrug-eluting Dissolvable Plugs for Glaucoma Tubes
2024Sean Wang, MDStanford University, Byers Eye Institute at StanfordDelivering RNA Medicines to the Corneal Endothelium Using Charge Altering Nanoparticles
2023Bertan Cakir, MDHarvard/Massachusetts Eye and EarNon-invasive Redox Assessment of Mitochondria at the Optic Nerve Head Predicting Retinal Ganglion Cell Loss
2023Ken Kitayama, MD, MPHUniversity of California, Los AngelesRacial/Ethnic Disparities in Glaucoma Surgical Outcomes in California Medicare Beneficiaries
2023Elise Ma, MD, PhDUniversity of California, Los AngelesImpact of Aging on Retinal Ganglion Cell and Glial Cell Responses to Optic Nerve Injury
2023Warren Pan, MDUniversity of MichiganActivation of PKM2: A Gene Agnostic, Novel Treatment to Prevent Photoreceptor Degeneration in Retinitis Pigmentosa
2022Jonathan B. Lin, MD, PhDHarvard/Massachusetts Eye and EarSystemic Complement Application in Non-Exudative Age-Related Macular Degeneration
2022Micalla Peng, BSUSC/Keck School of MedicineElectronic Fields Direct Optic Nerve Regeneration and Partial Recovery of Vision after Crash
2022Linus Shen, MDUniversity of California, San FranciscoA Hierarchical Bayesian Change Points Method to Study the Long-Term Natural History of Diseases
2022Tu Tran, MD, MSCUniversity of MinnesotaCryptococcal Meningitis Eye Study
2021Andrew X. Chen, BSECleveland Clinic, Cole Eye InstituteFunctional Imaging of Mitochondria in Retinal Diseases Using Flavoprotein Fluorescence
2021Ines Lains, MD, PhDHarvard/Massachusetts Eye and EarGenetic-Metabolomic Assocations Support Role of LIPC Gene and and Glycerophospholipds in Age-Related Macular Degeneration
2021Nathan Pirakitikulr, MD, PhDUniversity of Miami, Bascom Palmer Eye InstituteA Simple Tool for Measuring Globe Position Using 3D Structured Light Scanning
2021Murtaza Saifee, BS, MDUCSF Department of OphthalmologyDevelopment and Validation of Automated Visual Field Report Extraction Platform Using Computer Vision Tools
2020Mathieu Bakhoum, MD, PhDUC San DiegoDissecting Uveal Melanoma One Cell at a Time
2020Siddharth Narendran, MDUniversity of VirginiaRole of Mechanotransduction in Age-Related Macular Degeneration
2020Brian T. Soetikno, PhDNorthwestern University/Feinberg School of MedicineVisible-Light Optical Coherence Tomography for Retinal Oximetry from Rodents to Humans
2020Harris Sultan, MD, MS Washington University School of MedicineVitreous Microparticles in Diabetic Eye Disease Signal Hyalocyte Apoptosis Suggesting a Diabetic Vitreopathy
2019Joshua Barnett, MD, PhDVanderbilt University Medical CenterTaurocholic Acid Prevents Progression of Age-Related Macular Degeneration in In-Vitro Models
2019Karine D. Bojikian, MD, PhDUniversity of Washington Macular Vascular Microcirculation in Eyes with Open Angle Glaucoma Using Different Visual Field Severity Classification Systems
2019Jason Matthew Lewis Miller, MD, PhDUniversity of Michigan Measuring and Modulating Lipid Handling Pathways in the RPE: Implications for Age-Related Macular Degeneration
2019Nandini Venkateswaran, MDBascom Palmer Eye InstituteThe Use of High Resolution Anterior Segment Optical Coherence Tomography (AS-OCT) for the Diagnosis and Differentiation of Conjunctival Lymphoma, Conjunctival Amyloidosis and Benign Lymphoid Hyperplasia
2018Joshua C Gross, BS, MDUniversity of Louisville Baseline Retinal Blood Flow and ONH Parameters Predict Structural and Functional Progression in OAG with DM
2018Cynthia Montana, MD, PhDWashington University in St. Louis Transcription Factor-Based Photoreceptor Programming
2018Nakul Shekhawat, MD, MPHUniversity of Michigan/Kellogg Eye CenterTopiramate-Induced Angle Closure Glaucoma: Far More Common than Previously Reported
2018Thomas Wubben, MD, PhDUniversity of Michigan/Kellogg Eye CenterPhotoreceptor Metabolic Reprogramming Inhibits Apoptosis in Acute Stress While Causing Chronic Degeneration
2017Shinichi Fukuda, MD, PhDUniversity of Virginia School of MedicineEndogenous Complementary DNA in Age-Related Macular Degeneration
2017Sabrina Mukhtar, BAUniversity of Pittsburgh Medical CenterMesenchymal Stem Cells Interact with Corneal Limbal Epithelial Cells by Mitochondrial Transfer via Tunneling Nanotubes
2017Lev Prasov, MD, PhDUniversity of Michigan/Kellogg Eye Center Genetics of Nanophthalmos
2017Brittni A. Scruggs, MD, PhDUniversity of IowaOptimizing Subretinal Injection Conditions for Retinal Gene and Stem Cell Therapy
2016Brian Ballios, MD, PhDUniversity of TorontoAn Injectable Hydrogel Improves the Survival and Functional Integration of Stem Cell Progeny Transplanted into Adult Retina
2016Kai B. Kang, MDIllinois Eye and Ear InfirmaryMicro- and Nanoscale Surface Topographies on Silk Regulate Cytoskeletal Dynamics and Gene Expression of Human Corneal Epithelial Cells
2016John Thomas Gaikens Pena, MD, PhDWeill-Cornell Department of OphthalmologymicroRNAs Regulate Macular Edema
2016Amirfarbod Yazdanyar, MDState University of New York (SUNY)Overexpression of Phospholipid Transfer Protein (PLTIP) Induces Sub-Retinal Drusen and Ellipsoid Layer Disruption in Mice Fed with High Fat/Carbohydrate Diet
2015Ana Bastos-Carvalho, MD, PhDUniversity of KentuckyIgG1 Antibodies Generically Inhibit Ocular Neovascularization
2015Mehnaz Khan, MD, MSUniversity of Michigan/Kellogg Eye CenterEpigenetics of Retinoblastoma
2015Kabhilan Mohan, MS, PhDUniversity of KentuckyIn Vivo Imaging of Retinal Pigment Epithelium Cell Death Using Caspase Targeted Fluorescent Probes
2015Jeffrey Jing Tan, MDSUNY DownstateLong-Term Adverse Effects in Intravitreal Bevacizumab In Rat Model of Retinopathy of Prematurity 
2014Benjamin Fowler, MD, PhDUniversity of KentuckyNucleoside Reverse Transcriptase Inhibitors Are Anti-Inflammatory and Prevent Dry Eye
2014Mohamed Abou Shousha, MD, MS, FRCS, PhDSaint Louis University Eye InstituteIn Vivo Descemet's Membrane Thickness: A Novel Idea Criteria for the Diagnosis of Corneal Graft Rejection
2014Guadalupe Villarreal, Jr., MDWilmer Eye Institute, Johns Hopkins HospitalCanonical Wnt Signaling Regulates Extracellular Matarix Expression in the Trabecular Meshwork
2014Glenn Yiu, MD, PhDDuke University Eye CenterCharacterization of the Choroid-Sceral Junction and Suprachoroidal Layer in Healthy Subjects on Enchancing-Depth Imaging Optical Coherence Tomography
2013Derick Gary Holt, MD, PhDUniversity of UtahRaver2 Preserves Corneal Avascularity by Regulating mRNA Processing of the VEGF Decoy Receptors sFIt
2013Aaron Lee, MDWashington University in St. Louis, School of MedicineDeep Sequencing Techniques in Infectious Endophthalmitis
2013Jared Knickelbein, MDUniversity of Pittsburgh School of MedicinMechanisms of Accelerated Corneal Graft Rejection in HSV-Infected Hosts
2013Yannis Paulus, MDStanford University, Byers Eye Institute at StanfordOral Niacin as a Treatment for Retinal Vein Occlusions
2012Brenda Bohnsack, MD, PhDDuke University Eye CenterThyroid Hormone is Required for Ocular and Craniofacial Development via Interactions with Retinoic Acid on the Neural Crest
2012Eric Nudleman, MD, PhDDepartment of Ophthalmology, Washington University School of MedicineActivation of the Wnt Signaling Pathway in Neovascularization
2012Veeral Shah, MD, PhDUPMC Eye CenterIntrinsic properties guide proximal abducens and oculomotor nerve outgrowth
2012Nahyoung Grace Lee, MDCasey Eye Institute, Oregon Health & Science UniversityGene Expression Profiling in Nonspecific Orbital Inflammation Using Microarray Analysis
2011Manik Goel, MDBascom Palmer Eye InstituteCochlin Expression in Mice Trabecular Meshwork Influences Repulation of Intraocular Pressure
2011Ajay Kuriyan, MDFlaum Eye Institute, University of Rochester Medical CenterElectrophilic PPARγ Ligands Inhibit Corneal Fibroblast to Myofibroblast Differentiation In Vitro: A Potential Novel Therapy for Corneal Scaring
2011Rithwick Rajagopal, MDWashington University School of MedicineSilencing of Mitf, The Master Regulatory Gene for Melanocyte Differentiation, Results in Profound Changes in the Phenotype of Uveal Melanoma Cell
2011Dimitra Skondra, MD, PhDWeill Cornell Medical College, Dept. of OphthalmologyMoist Cells Mediate Laser Induced Choroidal Neovascularization through Fibroblast Activation
2010Emmanuel Yih-Herng Chang, MD, PhDBaylor College of MedicineBiodegradable Microparticle-Based Drug Delivery Systems for Modulating Ocular Surface Disease
2010Paul Hahn, MD, PhDScheie Eye Institute/University of PennsylvaniaA Putative Role for Iron-Induced Oxidative Stress in the Pathogensis of Age-Related Macular Degeneration
2010Anton Orlin, MDScheie Eye Institute/University of PennsylvaniaAnalysis of Six Genetic Risk Factors Highly Associated with AMD in the Region Surrounding ARMS2 and HRTA1 on Chromosome 10q26
2010Andrew M. Schimel, MDWashington University in St. LouisA Novel Antioxitant Prevents Retinal Degeneration by Promoting Glutathione and reducing Lipid Perioxidation in Retinal Pigment Epitheal Cells and Mice
2009Romulo Albuquerque, DDS, MSUniversity of KentuckysVEGFR-2 A Novel Endogenous Inhibitor of Corneal Lymphangiogenesis and Allograft Rejection
2009Vincent S. Hau, MD, PhDJohn A. Moran Eye Center, University of UtahPromotor Polymorphism of the Erythropoietin Gene in Severe Diabetic Eye and Kidney Complications
2009Mark E. Kleinman, MDUniversity of KentuckyToll-like Receptor 3 in Geographic Atropy: Deciphering Mechanics and Developing Therapies
2009David M. Wu, MD, PhDUniversity of Michigan, Kellogg Eye Centermm3342: A New Mouse Model of Retinal Degeneration and Its Role in Understanding Retinal Disease
2008Shu-Hong (Holly) Chang, MDWashington University in St. LouisPrognostics Biomarkers in Uveal Melanoma: Evidence for a Cancer Stem Cell Phenotype?
2008Sai Hemanth Chavala, MDDuke University Eye CenterActivation of the p53 Pathway by MDM2 Blockade Inhibits Early Retinal Vascular Development
2008Maria Soledad Cortina, MDLouisiana State UniversityThe Combination of PEDF and DHA Increases Regeneration of Corneal Nerves  after Surgery
2008Holly Butler Hindman, MDUniversity of RochesterEndothelial Keratoplasty and Ocular Optics
2007Jennifer Fisher, MDUniversity of California, San FranciscoMicrosurgical Lab Testing Is a Reliable Method for Assessing Ophthamology Residents' Surgical Skills
2007Alon Kahana, MD, PhDUniversity of WisconsinThe Study of Orbital Development using Zebrafish: A Powerful Tool for Understanding Orbital Biology and Disease
2007Hatice Nida Sen, MDGeorge Washington UniversitySystemic Nonsteroidal Anti-Inflammatory Medications and Age-Related Macular Degeneration: The Age-Related Eye Disease Study (AREDS)
2007Alison Skalet, MD, PhDUniversity of California, San FranciscoTelemedicine Screening for ROP in Developing Countries Using Digital Retinal Images
2006Jeffrey L. Goldberg , MD, PhD University of Miami, Bascom Palmer Eye InstituteRetinal Ganglian Cell Death after Axon Injury: The Role of Physiologic Levels of Electrical Activity
2006Michael Grassi , MDUniversity of Iowa Hospitals and ClinicsEthnic Variation in AMD-Associated Complement Factor H Polymorphism Y402H
2006Scott Lee , MD, PhD University of CaliforniaTrachoma in Flies and Children after Azithromycin Treatment: Should We Rethink the WHO Paradigm?
2006Miho Nozaki , MDUniversity of KentuckyCorneal Avascularity Is Due to Soluable VEGF Receptor-1
2005Jared Nielsen , MDLoyola UniversityEffect of Basic Fibroblast Growth on Adult Human Retinal Stem Cell Proliferation In Vivo
2005Mark I. Rosenblatt , MD, PhDMassachusetts Eye & Ear InfirmaryGene Transfer of an Anti-Angiogenic Metalloproteinase to Cornea-Derived Cells
2005Robert Keith Shuler Jr. , MDEmory University School of MedicineGene Therapy by Genoplasty in Retinal Tissue
2005Newman J. Sund, MD, PhDScheie Eye Institute, University of PennsylvaniaRetinal Oxygen Imaging in Mice by Phosphorescence Lifetime
2004Maya Eibschitz-Tsimhoni, MDUniversity of MichiganA Molecular Approach to the Management of Graves Ophthalmology
2004Pedram Hamrah , MDUniversity of Louisville/Ophthalmology DepartmentBreaking a Dogma: Evolving   Story of Corneal Antigen Presentation
2004Murat Kalayoglu, MD, PhDMassachusetts Eye & Ear InfirmaryChlamydia Pneumoniae Induces Production of Vascular Endothelial Grown Factor In Vitro and is Identified in Human Choroidal Neovascular Membranes Secondary to Age-Related Macular Degeneration
2004Wai T. Wong , MDNational Institutes of HealthEffect of Over-Expression in Pigment Epithelium-Derived Factor (PEDF) on Developing Retinal Vasculature in the Mouse Eye
2003Leonard Feiner, MD, PhDScheie Eye Institute, University of PennsylvaniaAdult onset neovascularization in the mouse caused by cell specific loss of the von Hippel Lindau gene
2003Dino Klisovic, MDThe Ohio State UniversityDepsipeptide, a Histone Deacetylase Inhibitor, Inhibits Proliferation, Induces Apoptosis and Inhibits Migration of Primary and Metastatic Uveal Melanoma Cell Lines in Vitro: a Potential Therapeutic Strategy for Uveal Melanoma
2003David H. Ren , MD, PhDUniversity of Texas Southwestern Medical Center at DallasTumor Necrosis Factor (TNF) – Related Apoptosis-Inducing Ligand (TRAIL) Induces Apoptosis in Human Uveal Melanoma Cells
2003Stephen H. Tsang, MD, PhDJules Stein Institute, UCLA School of MedicineGenetic Switches for Retinal Gene Expression
2002Milam A. Brantley, Jr., MD, PhDWashington UniversityMolecular Changes Associated with Local Therapy of Uveal Melanomas
2002Michael S. Ibarra , MDUniversity of Pennsylvania, Scheie Eye InstituteDetermination of Retinal and Subretinal Thermal Dosimetry from Transpupillary Thermotherapy
2002Kevin C. Lee , MDMount Sinai School of MedicineRetinal Pathology in DBA/2NNia Glaucomatous Mice
2002Danny Y. Lin , MDStanford UniversityThe Sensitivity and Specificity of Single Field Nonmydriatic Monochromatic Digital Fundus Photography with Remote Image Interpretation for Diabetic Retinopathy Screening: A Comparison with Ophthalmoscopy and Standardized Mydriatic Color Photography
2001Rajendra S. Apte , MD, PhDWashington UniversityRole of Angiostatin Produced by Certain Primary Intraocular Melanomas in Inhibiting The Development of Metastases
2001Yu-Guang He, MD University of Washington/OphthalmologyPhenotypic Defects of RPE65 Null Mutation and Recovery of Photopigment and Vision in the RPE65 Null Mutant Murine Model of Leber Congenital Amaurosis
2001Albert S. Jun , MD, PhDWilmer B-20, The Johns Hopkins HospitalDNA Microarray Analysis of Human Donor Corneas
2001Nariman Sharara, MD Emory University Eye CenterMurine High Fat Die/Laser Photochemical Model of Basal Deposits in Bruch's Membrane
2001Stephen H. Tsang, MD, PhD Jules Stein Eye Institute, UCLAToward Repair of Retinal Degenerations with Differentiated and Embryonic Stem (ES) Cells
2000Jayakrishna Ambati, MDMassachusetts Eye & Ear InfirmaryTargeted Transcleral Delivery of Bioactive Proteins to the Choroid and Retina
2000Bienvenido V. Castillo, Jr., MD University of Illinois at ChicagoRibozyme Gene Therapy in a Transgenic Mouse Model for Autosomal Dominant Congenital Stationary Night Blindness (CSNB)
2000Min Cheol Kim, MD, PhD Wilmer Ophthalmological Institute/Johns Hopkins HospitalSecure Personal Identification using the limbal palisades of Vogt
2000Hanna Levkovich-Verbin, MD Wilmer Ophthalmological Institute/Johns Hopkins HospitalDoes secondary degeneration occur in primate retinal ganglion cells?
2000Andrew John Lotery, MD University of Iowa Hospitals and ClinicsDiscovery of the Malattia Leventinese/Doyne Gene and its Relevance to AMD
2000Michael J. Tolentino, MD Scheie Eye InstituteVEGF induced preretinal neovascularization and intraretinal edema in a nonhuman primate
1999Rajendra S. Apte, MD, PhDUT Southwestern Medical CenterImmune Privilege and Intraocular Tumor Surveillance
1999Linda E. Day, MDUniversity of WashingtonSoluble Growth Factors Improve Integration Between Healthy and Diseased Retinas In Vitro
1999Alan J. Franklin, MD, PhDUniversity of IowaCarboxyamido-Triazole is a Potent Inhibitor of Retinal Neovascularization
1999Yu-Guang He, MDUT Southwestern Medical CenterOral Tolerance: A Novel Strategy for Preventing Immunologic Rejection of Corneal Allograft
1999Russell N. Van Gelder , MD, PhDWashington UniversityMultiplex PCR for Detection of Uveitis Pathogens
1998Jayakrishna Ambati, MDUniversity of RochesterElevated GABA, Glutamate, and Vascular Endothelial Growth Factor Levels in the Viteous of Patients with Proliferative Diabetic Retinopathy
1998Jeremiah Brown, Jr., MS, MDUniversity of IowaClinical Characterization and Linkage Analysis of a Four Generation Family with Cone-Rod Dystrophy
1998Joshua L. Dunaief, MD, PhDWilmer Ophthalmological InstituteRetinoblastoma Protein Complexes Involved in Cell Cycle Control
1998John H. Fingert, MDUniversity of IowaIdentification of a Gene That Causes POAG
1998Jun C. Huang, MD, PhDUniversity of Medicine and Dentistry of New JerseyPreparation and Transplanation of Photoreceptor Sheets
1998Jonathan Sears, MDEmory UniversityRetinal Glyceraldehyde-3-phosphate Dehydrogenase is Recognized by Autoantibodies in Patients with Cancer
1998Agnes M.F. Wong, MDUniversity of TorontoRepresentation of the Visual Field in Human Occipital Cortex:  A Correlation Between MRI and Visual Field Defects
1997Jorge G. Arroyo, MDDuke UniversityA Novel Method for the Localized Delivery of Enzymes into the Ocular Circulation:  Intravascular Photoactivation of Caged-Thrombin
1997Jeffrey W. Berger, MD, PhDUniversity of PennsylvaniaSlit-Lamp Fundus Biomicroscopy of the Future--Design Considerations and Prototype Construction
1997John Danias, MD, PhDMt. Sinai School of MedicineIntravitreal Anti-Sense Oligonucleotides to Glutamate Dehydrogenase (GDH):  Effects on ERGs in Rats
1997Gustavo Alejandro Gonzalez, MD, MS, PhDUniversity of California, San FranciscoImproved Genetic Testing for the Retinoblastoma Gene
1997Torben Moller-Pedersen, MDUniversity of Texas, DallasQuantitative Evaluation of Excimer Laser PRK Using in Quantitative Evaluation of Excimer Laser PRK Using in Vivo Confocal Microscopyivo Confocal Microscopy
1997Peter L. Sonkin, MDUniversity of IowaThe Effects of Pentoxifylline on the Progression of Diabetic Retinopathy
1997Kang Zhang, MD, PhDWilmer Institute, Johns Hopkins UniversityGenetic and Molecular Analysis of Stargardts' Macular Dystrophy

Nominees for the Resident and Fellow Research Forum must fulfill the following criteria:

  • Ophthalmology residents in accredited programs in the United States or Canada or clinical fellows in AUPO FCC compliant or ASOPRS programs carrying out research on a full or part time basis. Medical students doing a full year of research are also eligible.
  • Research content should reflect ongoing or very recent research that has not yet been published or accepted for publication at the time of submission.
  • Applications across the full spectrum of ophthalmic diseases are encouraged.
  • A winning presenter is eligible to present only once at an AUPO annual meeting.

  • Candidates must be nominated by their Department Chair
  • The Application Packet must include the following items (10 pt. font or greater):
    • A letter (not to exceed two pages) from the Chair summarizing the Nominee’s special qualifications for the Award and verifying
      • the percent of ‘hands-on’ effort by the candidate described in the abstract
      • the cash prize will be awarded directly to the Awardee and not counted against normal compensation or deposited in department accounts
      • the Awardee will attend the AUPO Annual Meeting to receive the award and will be accompanied by the Chair or another Member from their department
    • One-page curriculum vitae
    • Abstract of research carried out by candidate
      • abstracts should indicate the percent of “hands-on” effort of the work performed by the candidate
      • abstracts should be in ARVO format
      • the introduction should contain a single sentence statement of the hypothesis
      • the conclusion should contain a single sentence statement of the relevance of the work to the prevention of blindness (why the study is therefore important)
  • No candidate may submit more than one abstract, although there is no limit to the number of abstracts that may be submitted from any department. In general, there should be only one submission from the laboratory or program of an individual scientific faculty preceptor.

The completed application packet must be compiled by the Department Chair and submitted electronically by the September deadline.

  • All applications will be reviewed by a Selection Committee, consisting of Chairs and Directors of Research from Departments of Ophthalmology.
  • The four successful candidates will be notified in October.